Aktieanalys

Amniotics: Orphan Drug Designation for PulmoStem - Redeye

{newsItem.title}

Redeye Publicerad: 21 Nov 2023 08:35

Redeye has a positive view of PulmoStem obtaining orphan drug designation for lung transplantation from the EMA, which we discuss briefly.

Länk till analysen i sin helhet: https://www.redeye.se/research/961968/amniotics-orphan-drug-designation-for-pulmostem?utm_source=finwire&utm_medium=RSS

Nyheter om Amniotics

Läses av andra just nu

Om aktien Amniotics

Senaste nytt